Publication | Open Access

Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes

InflammationThrombosisThrombopoiesisEndothelial CellsChemotherapeutic Agents DoxorubicinMedicineHematologyImmunologyPathologyHemostasisEndothelial DysfunctionVascular BiologyPharmacotherapyBlood MonocytesPharmacologyAnticoagulantAtherosclerosis